$AGEN
Agenus Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Lexington, MA
AGEN chart
What traders are saying about $AGEN
Latest postsAgenus Inc news
- Agenus Inc. (AGEN) stock price, news, quote and history
Yahoo Finance UK ·
- Weekly Recap: BOT+BAL Phase 2 strong responses and Q3 2026/ROBBIN updates
TradingView ·
- Why Are ArriVent (NASDAQ:AVBP), Agenus (NASDAQ:AGEN), Corvus (NASDAQ:CRVS) and Contineum (NASDAQ:CTNM) Rising Premarket?
Kalkine ·
- Why Are Surgery Partners (NASDAQ:SGRY), ArriVent (NASDAQ:AVBP), XMAX (NASDAQ:XMAX) and Agenus (NASDAQ:AGEN) Leading Premarket Gainers?
Kalkine ·
- Agenus (AGEN) Reports Promising Phase 2 Colon Cancer Trial Resul
GuruFocus ·
- Agenus Reports 72% Pathologic Complete Response in dMMR Colon Cancer Cohort
www.tokenpost.com ·
- Agenus reports response rate in colon cancer trial (AGEN:NASDAQ)
Seeking Alpha ·
- Agenus: 72% of patients cancer-free at surgery after six-week immunotherapy course in Phase 2 NEOASIS
Dealroom ·
- Agenus Reports 72% Pathologic Complete Response Rate with BOT+BAL in Phase 2 NEOASIS Trial at ESMO 2026
Oncodaily ·
- Phase 2 colon cancer data from Agenus show 72 percent pathologic complete response
Traders Union ·
- Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
Yahoo Finance ·
- Agenus Inc. (AGEN) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
Agenus Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $114.2M | $103.5M | $156.3M | $98.0M |
| Net income | -$3.1M | -$232.3M | -$257.4M | – |
| Diluted EPS | $0.00 | $-10.59 | $-13.75 | $-15.64 |
| Total assets (year end) | $226.8M | $226.3M | $313.9M | $413.6M |
| Cash and equivalents (year end) | $3.0M | $40.4M | $76.1M | $178.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Agenus Inc
- Ticker
- AGEN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Lexington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1098972
- Former names
- ANTIGENICS INC /DE/
Frequently asked questions
What exchange is Agenus Inc listed on?
Agenus Inc trades on the Nasdaq under the ticker symbol AGEN.
What industry is Agenus Inc in?
Agenus Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Agenus Inc headquartered?
Agenus Inc's business address on file with the SEC is in Lexington, MA.
When does Agenus Inc's fiscal year end?
Agenus Inc's fiscal year ends on December 31.
How much revenue did Agenus Inc report?
Agenus Inc reported $114.2M in revenue for calendar year 2025, according to its SEC filings.